Company news
Allgens Medical Technology Co. Ltd. news in 2025
Allgens Medical Technology Co. Ltd.'s news releases, calls and decks from 2025, newest first.
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
December 26, 2025
Announcement on Changing Project Quality Control Reviewer of Audit Institution
December 23, 2025
Announcement on Signing Tripartite Supervision Agreement for Deposit of Raised Fund in Special Account
December 8, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
November 26, 2025
Announcement on Shareholding Reduction Plan of Directors and Senior Management Members
November 10, 2025
Announcement on Closing Partial Investment Projects Financed by Raised Funds, Using Residual Raised Funds to Permanently Supplement Current Capital, and Cancellation of Related Special Account for Raised Funds
October 29, 2025
Announcement on the Completion and Results of Share Reduction Plan for Shareholders with Over 5% Shares
October 27, 2025
Announcement on Voluntary Disclosure of the Company Product Obtaining the Registration Certificate
September 28, 2025
Announcement on Shareholding Reduction Plan for Shareholders
September 23, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 15, 2025
Announcement on Abnormal Fluctuations in Stock Trading
September 8, 2025
Announcement on Attending the Semi-annual Collective Performance Briefing for Medical Device and Equipment Companies on SSE STAR Market 2025
September 5, 2025
Announcement on the Resignation of Non-independent Director and General Manager and By-election of Non-independent Director and Appointment of General Manager
August 29, 2025
Announcement on the Return of Idle Raised Funds to Temporarily Supplement Current Capital
August 19, 2025
Announcement on Canceling Special Account for Raised Funds
July 23, 2025
Announcement on Voluntary Disclosure of the Company Product Obtaining the Registration Certificate in Vietnam
July 21, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
July 11, 2025
Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2024 Annual Report
July 4, 2025
Announcement on Voluntary Disclosure of Subsidiary Obtaining a Medical Device Production License
July 1, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
June 25, 2025
Announcement on Voluntary Disclosure of Obtaining Registration Certificates for Company Products in Vietnam
June 17, 2025
Announcement on the Death of Mr. Cui Fuzhai, One of the Founders and Actual Controllers of the Company
June 16, 2025
Announcement on Correction of 2024 Annual Report
May 30, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 16, 2025
Announcement on Vesting Results and Share Listing in the 2nd Vesting Period of Initial Grant in 2023 Restricted Stock Incentive Plan
April 30, 2025
Report for Q1 2025
April 25, 2025
Announcement on Preliminary Earnings Estimate for 2024 and Correction of Earnings Preannouncement
April 24, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Voluntary Disclosure of Obtaining Registration Certificates for Company Products in Indonesia
February 18, 2025
Announcement on Expected Losses in Annual Performance for 2024
January 24, 2025
Announcement on Completion of Share Reduction Plan and Reduction Results for Shareholders with Over 5% Shares
January 13, 2025
Announcement on the Change of Project Quality Control Reviewer by the Audit Institution
January 7, 2025